Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (161-170 of 266) with videos related to

Pageof 27
Sort By:
Immunity|October 16, 2004
Role of LAG-3 in regulatory T cellsChing-Tai Huang, Creg J Workman, Dallas Flies, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2022
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck CancerAleksandar Obradovic, Diana Graves, Michael Korrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerMatthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumorsMichael C Haffner, Diana Taheri, Eddie Luidy-Imada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.
Pageof 27

Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
Immunity|October 16, 2004
Role of LAG-3 in regulatory T cellsChing-Tai Huang, Creg J Workman, Dallas Flies, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cellsDerese Getnet, Charles H Maris, Edward L Hipkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2022
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck CancerAleksandar Obradovic, Diana Graves, Michael Korrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerMatthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumorsMichael C Haffner, Diana Taheri, Eddie Luidy-Imada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.
Pageof 27